In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Zura Bio Ltd (NASDAQ: ZURA) closed at $1.39 in the last session, up 2.96% from day before closing price of $1.35. In other words, the price has increased by $2.96 from its previous closing price. On the day, 0.67 million shares were traded. ZURA stock price reached its highest trading level at $1.42 during the session, while it also had its lowest trading level at $1.35.
Ratios:
We take a closer look at ZURA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 8.14 and its Current Ratio is at 8.14. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on November 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $15.
On September 05, 2024, H.C. Wainwright started tracking the stock assigning a Neutral rating and target price of $5.
On May 03, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $26.Piper Sandler initiated its Overweight rating on May 03, 2024, with a $26 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 25 ’24 when Thiara Parvinder sold 1,001,633 shares for $2.73 per share. The transaction valued at 2,734,458 led to the insider holds 0 shares of the business.
Thiara Parvinder sold 3,800,000 shares of ZURA for $10,260,000 on Sep 11 ’24. The Director now owns 1,001,633 shares after completing the transaction at $2.70 per share. On Sep 04 ’24, another insider, Sidhu Someit, who serves as the Director of the company, sold 51,728 shares for $3.87 each. As a result, the insider received 200,187 and left with 2,085,418 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZURA now has a Market Capitalization of 88554536 and an Enterprise Value of -92396256.
Stock Price History:
The Beta on a monthly basis for ZURA is -0.10, which has changed by -0.6253369 over the last 52 weeks, in comparison to a change of 0.11844492 over the same period for the S&P500. Over the past 52 weeks, ZURA has reached a high of $5.07, while it has fallen to a 52-week low of $0.97. The 50-Day Moving Average of the stock is 17.82%, while the 200-Day Moving Average is calculated to be -35.90%.
Shares Statistics:
According to the various share statistics, ZURA traded on average about 561.46K shares per day over the past 3-months and 1086210 shares per day over the past 10 days. A total of 68.37M shares are outstanding, with a floating share count of 38.63M. Insiders hold about 37.57% of the company’s shares, while institutions hold 60.97% stake in the company. Shares short for ZURA as of 1749772800 were 2668914 with a Short Ratio of 4.75, compared to 1747267200 on 2509174. Therefore, it implies a Short% of Shares Outstanding of 2668914 and a Short% of Float of 4.78.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
